Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06000592 · ClinicalTrials.gov registry record · NA

Safety, Feasibility, and Efficacy of TSCS on Stabilizing Blood Pressure for Acute Inpatients With SCI

A NA study of Spinal Cord Injuries and Blood Pressure, sponsored by Jill M. Wecht, Ed.D..

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT06000592: Recruiting NA study of Spinal Cord Injuries and Blood Pressure, sponsored by Jill M. Wecht, Ed.D..

NCT06000592 is a NA study of Spinal Cord Injuries and Blood Pressure that is actively recruiting participants, run by Jill M. Wecht, Ed.D.. The registered enrollment target is 50 participants, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (18% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06000592, a NA study of Spinal Cord Injuries and Blood Pressure, is actively recruiting participants, sponsored by Jill M. Wecht, Ed.D..

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

Current forms of pharmacologic and non-pharmacologic treatments for hypotension and orthostatic hypotension (OH) remain inadequate during acute inpatient rehabilitation (AIR) following a traumatic spinal cord injury (SCI). A critical need exists for the identification of safe, practical, and effective treatment options that stabilize blood pressure (BP) after traumatic SCI. Recent published evidence suggests that transcutaneous Spinal Cord Stimulation (TSCS) can be used to raise seated BP, and mitigate the falls in BP during orthostatic repositioning in individuals with chronic SCI. This site-specific project will focus on the use of TSCS to stabilizing seated BP and mitigate the fall in BP during orthostatic repositioning during AIR following traumatic SCI.

Primary Outcome

Blood pressure changes (mmHg) during the sit-up test with TSCS compared to no stimulation.

Interventions

  • DEVICE Digitimer

Study Locations (1)

New York

  • The Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2022-01-01
Est. Completion 2026-10-01
Phase NA
Jill M. Wecht, Ed.D.

1 total trials

What NCT06000592 shows while recruiting

NCT06000592 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (18% lower).

The record links to 8 conditions, with Spinal Cord Injuries appearing as the primary indexed condition, and to 1 intervention - of which Digitimer is the first listed.

NCT06000592 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06000592 about?

NCT06000592 is a clinical study titled "Safety, Feasibility, and Efficacy of TSCS on Stabilizing Blood Pressure for Acute Inpatients With SCI". Current forms of pharmacologic and non-pharmacologic treatments for hypotension and orthostatic hypotension (OH) remain inadequate during acute inpatient rehabilitation (AIR) following a traumatic spinal cord injury (SCI). A critical need exists for the identification of safe, practical, and effecti...

What is the current status of trial NCT06000592?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2022-01-01. Estimated completion is 2026-10-01.

What conditions does trial NCT06000592 study?

This clinical trial studies the following conditions: Spinal Cord Injuries, Blood Pressure, SCI - Spinal Cord Injury, Acute Spinal Cord Injury, Blood Pressure Disorders.

What interventions are being tested in trial NCT06000592?

The interventions under investigation include: Digitimer (DEVICE).

Who is sponsoring clinical trial NCT06000592?

This trial is sponsored by Jill M. Wecht, Ed.D., which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06000592 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06000592's enrollment target sits among peer trials

50 59th of 202 higher than 141 of 202 other Spinal Cord Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT06000592, the US trial registry maintained by the National Library of Medicine. NCT06000592 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.